ANALYSIS OF PRESCRIPTION TREND IN THE TREATMENT OF HEPATITIS C AND THE STUDY OF ASSOCIATION OF THIS THERAPY PLAN WITH THE AGE OF THE PATIENT

Main Article Content

Hammad Yousaf
Yasir Mehmood
Muhammad Imran Ashraf
Syed Asif Raza
Syed Saeed ul Hassan
Asad Bilal

Abstract

Objective: To check out the prescription trend for the hepatitis C i.e. to analyze the combination therapy. The association
of therapy plan with the age of the patient was also studied.
Material and Methods: Prescriptions were collected from 97 patients diagnosed with hepatitis C from December 2016
to February 2017. Statistical calculations were carried out on these prescriptions to analyze the trend and to see the
association of therapy plan with the age of the patient.
Results: In the prescription trend the combination of ribavirin 1200mg/day (400mg TID) and sofosbuver 400mg/day
was found to be the most frequent. Second frequent therapy was the combination of oral therapeutic agent (ribavirin
1200mg/day (400mg TID)) and an injectable (Peginterferonalfa 2a) whereas interferon alfa 2a were also used along
with the ribavirin. There was no association found between age of the patient and the therapy plan.
Conclusion: Oral therapy for the hepatitis C treatment is the most frequent therapy plan in the Jinnah hospital where
as the second frequent therapy plan was a combination of oral and the injectable. On the other hand there is no association
of age of patient with the therapy plan followed for hepatitis C.

Article Details

Section
Articles